Michael Erickson

President and Chief Executive Officer, Idexx Laboratories

Search every verified Michael Erickson interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Michael Erickson, executive vice president and incoming chief executive officer at IDEXX Laboratories, participated in the company’s first quarter 2026 earnings call on April 21, 2026. During the call, Erickson stated that he was “humbled by the opportunity to lead IDEXX” and described the sector as “highly attractive,” with a “meaningful opportunity ahead to further accelerate our innovation-driven platform growth strategy.” He said the company would continue to focus on diagnostics and software, where platforms “empower customers to see more and do more in their practices.” Erickson also discussed artificial intelligence as a priority, noting that IDEXX has “a well-established AI capability” embedded in platforms such as inView Dx and EasyVet software. He described advancements in AI as “incredibly promising to further accelerate our innovation, expand testing access and utilization, and drive deeper patient-level insights.” In the call, he attributed the company’s growth trends to volume-driven factors, including double-digit growth in point-of-care selling stock, a healthy reference lab business, and investments in cancer diagnostics and international expansion.